Article

Sublingual Immunotherapy For Environmental and Food Allergies Is Safe in Real-World Telemedicine Care: Evidence from 23,118 Patient-Years

2026-07-10

Abstract excerpt

<title>Abstract</title> <p>Background Sublingual immunotherapy (SLIT) is an effective disease-modifying treatment for allergic respiratory disease and is generally considered safer than subcutaneous immunotherapy. However, large-scale safety data from fully remote telemedicine-based care models remain limited. Methods This retrospective longitudinal observational study included patients receiving personalized S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d5b97e3f-7f12-5a14-893c-207aec5eb918
DOI: 10.21203/rs.3.rs-10232781/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sublingual Immunotherapy For Environmental and Food Allergies Is Safe in Real-World Telemedicine Care: Evidence from 23,118 Patient-YearsDOI 10.21203/rs.3.rs-10232781/v1Read

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial.Semantic proximity Read

Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: A pilot study in real-life .Semantic proximity Read

Oral Immunotherapy for cashew nut and peanut allergy in children -- a retrospective single-center studySemantic proximity Read

Teledermatology: an Evidence Map of Systematic ReviewsSemantic proximity Read

House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control -- a RWE studySemantic proximity Read

Title: Current options in the management of tree nut allergy, focusing on, but not limited to immunotherapy: A systematic review.Semantic proximity Read

Emerging Treatment Options for Peanut AllergySemantic proximity Read

A multi-disciplinary approach to the diagnosis and management of allergic diseases: An EAACI Task ForceSemantic proximity Read

Efficient Triage and Improved Patient Care: Five years of Teledermatology in StyriaSemantic proximity Read

Cutaneous adverse events associated with Rybrevant based on FDA Adverse Event Reporting System (FAERS) database from 2021 to 2024Semantic proximity Read

Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature reviewSemantic proximity Read

Prevalence, management and burden of mastocytosis from the physician’s perspective: A nationwide studySemantic proximity Read